Is Helicobacter pylori infection a cause of gastric neoplasia?

Cancer Surveys

Volumn 33, Issue , 1998, Pages 263-289

  Danesh, J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; CLARITHROMYCIN; OMEPRAZOLE; VACCINE;

ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; BACTERIAL INFECTION; CANCER GRADING; CAUSE OF DEATH; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; GEOGRAPHY; HELICOBACTER PYLORI; HUMAN; PRIORITY JOURNAL; REVIEW; STOMACH ADENOCARCINOMA; STOMACH TUMOR; TREATMENT PLANNING;

EID: 0032443014     PISSN: 02612429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (235)

1. Alkan S, Karcher DS, Newman MA and Cohen P (1996) Regression of salivary gland MALT lymphoma after treatment for Helicobacter pylori. Lancet 348 268-269
2. Aoki K (1980) Is the predisposition to stomach cancer determined before the age of 15? Proceedings of the 39th Annual Meeting of the Japanese Cancer Association 367 [Abstract]
3. Archimandritis A, Bitsakas J, Tjivras M et al (1993) Non-cardia gastric adenocarcinoma and Helicobacter pylori infection. Italian Journal of Gastroenterology 25 368-371
4. Aromaa A, Kosunen TU, Knekt P et al (1996) Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer. American Journal of Epidemiology 144 142-149
5. Asaka M, Kimura T, Kato M et al (1994) Possible role of Helicobacter pylori infection in early gastric cancer development. Cancer 73 2691-2694
6. Asaka M, Kato M, Kudo M et al (1995) Relationship between Helicobacter pylori infection atrophic gastritis and gastric carcinoma in a Japanese population. European Journal of Gastroenterology and Hepatology 7 (Supplement 1) S7-S10
7. Barreto-Zuniga R, Maruyama M, Kato Y et al (1997) Significance of Helicobacter pylori infection as a risk factor in gastric cancer: serological and histological studies. Journal of Gastroenterology 32 289-294
8. Bayerdorffer E, Neubauer A, Rudolph B et al for MALT Lymphoma Study Group (1995) Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. Lancet 345 1591-1594
9. Beales ILP, Crabtree JE, Scunes D, Covacci A and Calam J (1996) Antibodies to CagA protein are associated with gastric atrophy in Helicobacter pylori infection. European Journal of Gastroenterology and Hepatology 8 645-649
10. Blaser MJ (1997) Not all Helicobacter pylori strains are created equal: should all be eliminated? Lancet 349 1020-1022
11. Blaser MJ (1998) Helicobacter pylori and gastric diseases. British Medical Journal 316 1507-1510
12. Blaser MJ, Kobayashi K, Cover TL, Cao P, Feurer ID and Perez-Perez GI (1993) Helicobacter pylori infection in Japanese patients with adenocarcinoma of the stomach. International Journal of Cancer 55 799-802
13. Blaser MJ, Perez-Perez GI and Kleanthous H (1995) Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Research 55 2111-2115
14. Blecker U, McKeithan TW, Hart J and Kirschner BS (1995) Resolution of Helicobacter pylori-associated gastric lymphoproliferative disease in a child. Gastroenterology 109 973-977
15. Boixeda D, Gisbdert JP, Arocena C, Baleriola I, Martin de Argila C and Garcia Plaza A (1996a) Prevalencia de la infeccion por Helicobacter pylori en el adenocarcinoma gastrico y en la gastritis cronica. Revista Espanola de las Enfermedades del Aparato Digestivo 88 403-408
16. Boixeda D, Montalban C, Manzanal A et al (1996b) Sequential histological and molecular follow-up of low grade gastric MALT lymphoma after eradication therapy for Helicobacter pylori. Gut 39 (Supplement 3) A68
17. Boot H, de Jong P, van Heerde JMV and Burgers BG (1996) Role of Helicobacter pylori eradication in low grade and high grade gastric MALT lymphoma - early results. Gastroenterology 110 A493
18. Borda F, Echarri JM, Martinez-Penuela C, Valenti JM, Zozaya FJ and Jimenez FJ (1995) Helicobacter pylori prevalence and possible causality role in gastric lymphomas. Endoscopy 27 S18
19. Buckley M and O'Morain C (1995) Helicobacter pylori infection and gastric cancer: usefulness of screening high risk groups. Acta Gastro-Enterologica Belgica 58 382-387
20. Burke AP, Yen TSB, Shekitka KM and Sobin LH (1990) Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction. Modern Pathology 3 377-380
21. Cammarotta G, Montalto M, Tursi A, Vecchio Fm, Fedelli G and Gasbarrini G (1995a) Helicobacter pylori reinfection and rapid relapse of low-grade B-cell gastric lymphoma. Lancet 345 192
22. Cammarotta G, Tursi A, Montalto M et al (1995b) Prevention and treatment of low-grade B-cell primary gastric lymphoma by anti-H pylori therapy. Journal of Clinical Gastroenterology 21 118-122
23. Carlson SJ, Yokoo H and Vanagunas A (1996) Progression of gastritis to monoclonal B-cell lymphoma with resolution and recurrence following eradication of Helicobacter pylori. Journal of the American Medical Association 275 937-939
24. Cayla R, Carles B, de Mascarel A, Zerbib F and Lamouliatte H (1995) Long term follow-up of chronic gastritis after persistent Helicobacter pylori eradication in duodenal ulcer patients. Gastroenterology 108 A68
25. Chen SY, Liu TY, Chen MJ, Lin JT, Shen JC and Chen CJ (1997) Seroprevalences of hepatitis B and C viruses and Helicobacter pylori in a small isolated population at high risk of gastric and liver cancer. International Journal of Cancer 75 776-779
26. Chira C, Rovinaru I, Pop F, Raducan L, Copaci I and Vadan R (1996) Gastric cancer and Helicobacter pylori infection. Gut 39 (Supplement 3) A68
27. Choi NW, Entwistle DW and Michaluk W (1971) Gastric cancer in Icelanders in Manitoba. Israeli Journal of Medical Science 7 1500-1508
28. Ciok J, Dzienizweski J and Lucer C (1997) H pylori eradication promotes regression of antral intestinal metaplasia in a two year follow-up study. Gut 41 (Supplement 3) A170
29. Clarkson KS and West KP (1993) Gastric cancer and Helicobacter pylori infection. Journal of Clinical Pathology 46 997-999
30. Correa P (1988) A human model of gastric carcinogenesis. Cancer Research 48 3554-3560
31. Correa P (1991) Is gastric carcinoma an infectious disease? New England Journal of Medicine 325 1170-1171
32. Correa P (1992) Human gastric carcinogenesis: a multistep and multifactorial process. Cancer Research 52 6735-6740
33. Correa P (1994) How does Helicobacter pylori infection increase gastric cancer risk? European Journal of Gastroenterology and Hepatology 6 1117-1118
34. Correa P (1995) Helicobacter pylori and gastric carcinogenesis. American Journal of Surgical Pathology 19 (Supplement 1) S37-S43
35. Correa P (1996) Helicobacter pylori and gastric cancer: state of the art. Cancer Epidemiology, Biomarkers and Prevention 5 477-481
36. Correa P (1997) Helicobacter pylori and the cell cycle. Journal of the National Cancer Institute 89 836-837
37. Correa P, Fox J, Fontham E et al (1990) Helicobacter pylori and gastric carcinoma: serum antibody prevalence in populations with contrasting cancer risks. Cancer 66 2569-2574
38. Craanen ME, Blok P, Dekker W and Tytgat GN (1994) Helicobacter pylori and early gastric cancer. Gut 35 1372-1374
39. Crabtree JE, Forman D, Webb P, Newell D, Hengels KJ and Covacci A (1997) An association between CagA positive H pylori infection and the serum pepsinogens A:C ratio: evidence from an international cross-sectional study. Gut 41 (Supplement 1) A47
40. Crespi M and Citarda F (1996) Helicobacter pylori and gastric cancer: an overrated risk? Scandinavian Journal of Gastroenterology 31 1041-1046
41. Cutler A, Ma C and Schubert T (1993) Acute antral inflammation following Helicobacter pylori eradication. Gastroenterology 104 A60
42. Danesh J, Forman D, Collins R and Peto R (1996) Helicobacter pylori screening and gastric cancer. Lancet 348 758-759
43. Danesh J, Collins R and Peto R (1997a) Chronic infections and coronary heart disease: is there a link? Lancet 350 430-436
44. Danesh J, Newton R and Beral V (1997b) A human germ project? Nature 389 21-24
45. De Koster E, Buset M, Fernandes E and Deltenre M (1994) Helicobacter pylori: the link with gastric cancer. European Journal of Cancer Prevention 3 247-257
46. Drobyski WR and Qazi R (1989) Spontaneous regression in non-Hodgkin's lymphoma: clinical and pathogenetic considerations. American Journal of Hematology 31 138-141
47. Easterbrook P, Berlin J, Gopalan R and Matthews D (1991) Publication bias in clinical research. Lancet 337 867-872
48. Eidt S and Stolte M (1995) The significance of Helicobacter pylori in relation to gastric cancer and lymphoma. European Journal of Gastroenterology and Hepatology 7 318-321
49. Eidt S, Stolte M and Fischer R (1994) Helicobacter pylori gastritis and primary gastric non-Hodgkin's lymphomas. Journal of Clinical Pathology 47 436-439
50. Ellis KE and Fennerty MB (1996) Gastric malignancy. Gastroenterology Endoscopy Clinics of North America 6 545-563
51. Endo S, Ohkusa T, Saito Y, Fujiki K, Okayasu I and Sato C (1995) Detection of Helicobacter pylori infection in early stage gastric cancer. Cancer 75 2203-2208
52. Estevens J, Fidalgo P, Tendeiro T et al (1993) Anti-Helicobacter pylori antibodies prevalence and gastric adenocarcinoma in Portugal: report of a case-control study. European Journal of Cancer Prevention 2 377-380
53. Eurogast Study Group (1993) An international association between Helicobacter pylori infection and gastric cancer. Lancet 341 1359-1362
54. Farinati F, Foschia F, Carrao M, Di Mario F and Rugge M (1997) Helicobacter pylori eradication does not influence the natural history of gastric precancerous changes. Gut 41 (Supplement 3) A105
55. Feldman RA and Evans SJW (1995) Accuracy of diagnostic methods used for epidemiological studies of Helicobacter pylori. Alimentary Pharmacology and Therapeutics 9 (Supplement 2) 21-31
56. Filipe MI, Muñoz N, Matko I et al (1994) Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. International Journal of Cancer 57 324-329
57. Fiocca R, Luinetti O, Villani L et al (1993) High incidence of Helicobacter pylori colonization in early gastric cancer and the possible relationship to carcinogenesis. European Journal of Gastroenterology and Hepatology 5 (Supplement 2) S2-S8
58. Fischbach W, Kolve M-E and Dragosics B (1995) There is a difference in the prevalence of Helicobacter pylori between low grade and high grade primary gastric lymphoma of the MALT. Gastroenterology 108 A468
59. Fischbach W, Kolve ME, Greiner A et al (1997a) Primary gastric MALT lymphoma: a histology and stage stratified therapy. Gut 41 (Supplement 3) A34
60. Fischbach W, Tacke W, Greiner A, Konrad H and Hermelink M (1997b) Regression of immuno-proliferative small intestinal disease after eradication of Helicobacter pylori. Lancet 349 31-32
61. Fock KM, Khor CJL, Goh KT et al (1997) Seroprevalence of Helicobacter pylori infection and the incidence of gastric cancer in a multi-ethnic population. Gut 41 (Supplement 1) A50
62. Foester FC, Koch P, Tiemann M, Domschke W and Crabtree JE (1995) Serum response to Helicobacter pylori in primary B-cell gastric lymphoma. Gut 37 A6
63. Fontham ETH, Ruiz B, Preez A, Hunter F and Correa P (1995) Determinants of Helicobacter pylori infection and chronic gastritis. American Journal of Gastroenterology 90 1094-1101
64. Forman D (1991) Helicobacter pylori infection: a novel risk factor in the etiology of gastric cancer. Journal of the National Cancer Institute 83 1702-1703
65. Forman D (1995) The prevalence of Helicobacter pylori infection in gastric cancer. Alimentary Pharmacology and Therapeutics 9 (Supplement 2) 71-76
66. Forman D (1996a) Helicobacter pylori and gastric cancer. Scandinavian Journal of Gastroenterology 31 (Supplement 220) 23-26
67. Forman D (1996b) Helicobacter pylori and gastric cancer. Scandinavian Journal of Gastroenterology 31 (Supplement 215) 48-51
68. Forman D (1996c) Helicobacter pylori and gastric cancer. Scandinavian Journal of Gastroenterology 31 (Supplement 214) 31-33
69. Forman D (1998) Lessons from ongoing intervention studies, In: Hunt R and Tytgat G (eds). Helicobacter pylori: Basic Mechanisms to Clinical Cure 1998, Kluwer Academic Publishers, Dordrecht, The Netherlands
70. Forman D and Webb P (1993) Geographic distribution and association with gastric cancer, In: Northfield TC, Mendall MA and Goggin PM (eds). Helicobacter pylori Infection: Pathophysiology Epidemiology Management, pp 11-20, Kluwer Academic Publishers, Amsterdam, The Netherlands
71. Forman D, Sitas F, Newell DG et al (1990) Geographic association of Helicobacter pylori antibody prevalence and gastric cancer mortality in rural China. International Journal of Cancer 46 608-611
72. Forman D, Newell DG, Fullerton F et al (1991) Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. British Medical Journal 302 1302-1305
73. Forman D, Webb P and Parsonnet J (1994) H pylori and gastric cancer. Lancet 343 243-244
74. Fossati D, Alvisi C, Frego R, Perego M, Luinetti O and Fiocca R (1996) No change in intestinal metaplasia after H pylori eradication. Gut 39 (Supplement 2) A104
75. Franzin G, Zamboni G, Savio A et al (1996) Gastric MALT low-grade lymphoma: follow-up study after eradication of Helicobacter pylori. Gastroenterology 110 A109
76. Fraser AG, Scragg R, Metcalf D, McCullough S and Yeates NJ (1996) Prevalence of Helicobacter pylori infection in different ethnic groups in New Zealand children and adults. Australia and New Zealand Journal of Medicine 26 646-651
77. Fuchs CS and Mayer RJ (1995) Gastric carcinoma. New England Journal of Medicine 333 32-41
78. Fukao A, Komatsu S, Tsubono Y et al (1993) Helicobacter pylori infection and chronic atrophic gastritis among Japanese blood donors: a cross-sectional study. Cancer Causes and Controls 4 307-312
79. Fukuda H, Saito D, Hayashi S et al (1995) Helicobacter pylori infection serum pepsinogen level and gastric cancer: a case-control study in Japan. Japanese Journal of Cancer Research 86 64-71
80. Genta RM (1995) Helicobacter pylori as a promoter of intestinal metaplasia and gastric cancer: an alluring hypothesis in search of evidence. European Journal of Gastroenterology and Hepatology 7 (Supplement 1) S25-S30
81. Genta RM, Hamner HW and Graham DY (1993a) Gastric lymphoid follicles in Helicobacter pylori infection: frequency distribution and response to triple therapy. Human Pathology 24 577-583
82. Genta RM, Lew GM and Graham DY (1993b) Changes in gastric mucosa following eradication of Helicobacter pylori. Modern Pathology 6 281-289
83. Goldstone AR, Quirke P and Dixon MF (1996) Helicobacter pylori infection and gastric cancer. Journal of Pathology 179 129-137
84. Goodman KJ and Correa P (1995) The transmission of Helicobacter pylori: a critical review of the evidence. International Journal of Epidemiology 24 875-887
85. Goodwin CS, Mendall M and Northfield TC (1997) Helicobacter pylori infection. Lancet 349 265-269
86. Graham DY, Genta RM, Graham DP and Crabtree JE (1996a) Serum CagA antibodies in asymptomatic subjects and patients with peptic ulcer - lack of correlation of IgG antibody in patients with peptic ulcer or asymptomatic Helicobacter pylori gastritis. Journal of Clinical Pathology 49 829-832
87. Graham DY, Walsh JH, Schubert TT et al (1996b) Short-term treatment with ranitidine bismuth citrate (RBC) improves H pylori gastritis in the antrum and corpus. Gut 39 (Supplement 2) A24
88. Griffiths AE, Thursz MR and Walker MM (1997) Do intestinal metaplasia and gastric atrophy reverse after H pylori eradication? Gut 41 (Supplement 1) A48
89. Haenszel W (1958) Variation in incidence of and mortality from stomach cancer with particular reference to the United States. Journal of the National Cancer Institute 21 213-262
90. Haenszel W (1961) Cancer mortality among the foreign born in the United States. Journal of the National Cancer Institute 26 37-132
91. Haenszel W and Kurihara M (1968) Studies of Japanese migrants. I Mortality from cancer and other diseases among Japanese in the United States. Journal of the National Cancer Institute 40 43-68
92. Haenszel W, Kurihara M and Segi M (1972) Stomach cancer among Japanese in Hawaii. Journal of the National Cancer Institute 49 969-988
93. Halpern MT, Gillespie BW and Warner KE (1993) Patterns of absolute risk of lung cancer mortality in former smokers. Journal of the National Cancer Institute 85 457-464
94. Hansen S, Vollset SE, Melby K and Jellum E (1994) Strong association of previous Helicobacter pylori infection to distal gastric adenocarcinoma. American Journal Gastroenterology 89 1358 [Abstract]
95. Hansson LE, Engstrand L, Nyren O et al (1993) Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology 105 1098-1103
96. Hansson LE, Engstrand L, Nyren O and Lindgren A (1995) Prevalence of Helicobacter pylori infection in subtypes of gastric cancer. Gastroenterology 109 885-888
97. Hansson LE, Nyren O, Hsing AW et al (1996) The risk of stomach cancer in patients with gastric or duodenal ulcer disease. New England Journal of Medicine 335 242-249
98. Holcombe C (1992) Helicobacter pylori: the African enigma. Gut 33 429-431
99. Horstmann M, Erttmann R and Winkler K (1994) Relapse of MALT lymphoma associated with Helicobacter pylori after antibiotic treatment. Lancet 343 1098-1099
100. Howson CP, Hiyama T and Wynder EL (1986) The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiologic Reviews 8 1-27
101. Hussell T, Isaacson PG, Crabtree JE and Spence J (1993) The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 342 571-574
102. Igarashi H, Takahashi S, Ishiyama N et al (1992) Is Helicobacter pylori a causal agent in gastric carcinoma? Irish Journal of Medical Science 161 (Supplement 10) [Abstract GCE36]
103. Ihamaki T, Kekki M, Sipponen P and Siurala M (1985) The sequelae and course of chronic gastritis during a 30- to 34-year bioptic follow-up study. Scandinavian Journal of Gastroenterology 20 485-491
104. International Agency for Research on Cancer Working Group (1994) Monographs on the Evaluation of the Carcinogenic Risks to Humans: Schistosomes Liver Flukes and Helicobacter pylori 177-241
105. Isaacson P and Wright DH (1983) Malignant lymphoma of mucosa-associated lymphoid tissue: a distinctive type of B-cell lymphoma. Cancer 52 1410-1416
106. Isaacson PG and Spencer J (1987) Malignant lymphoma of mucosa-associated lymphoid tissue. Histopathology 11 445-462
107. Isakov VA and Gurevitch LE (1996) Low-grade MALT lymphoma of the stomach associated with Helicobacter pylori: Russian experience. Gut 39 (Supplement 3) A68
108. Jass JR and Filipe I (1979) A variant of intestinal metaplasia associated with gastric carcinoma: a histochemical study. Histopathology 3 191-199
109. Jass JR and Filipe MI (1980) Sulphomucins and precancerous lesions of the human stomach. Histopathology 4 271-279
110. Kang HC and Chung IS (1992) Helicobacter pylori infection and gastric adenocarcinoma in Korea: prevalence and distribution of H pylori in resected specimen of gastric cancer. Journal of Catholic Medical College 45 849-863
111. Kato S, Onda M, Matsukura N et al (1996) Genetic polymorphisms of the cancer related gene and Helicobacter pylori infection in Japanese gastric cancer patients. Cancer 77 1654-1661
112. Khulusi S, Mendall MA, Badve S, Patel P, Finlayson C and Northfield TC (1995) Effect of Helicobacter pylori eradication on gastric metaplasia of the duodenum. Gut 36 193-197
113. Kikuchi S, Wada O, Nakajima T et al (1995) Serum anti-Helicobacter pylori antibody and gastric carcinoma among young adults. Cancer 75 2789-2793
114. Kim HY, Cho BD, Chang WK et al (1997) Helicobacter pylori infection and the risk of gastric cancer among the Korean population. Journal of Gastroenterology and Hepatology 12 100-103
115. Kmet J (1970) The role of migrant populations in studies of selected cancer sites: a review. Journal of Chronic Disease 23 305-324
116. Kneller RW, Guo WD, Hsing AW, Chen JS, Blot WJ and Li JY (1992) Risk factors for stomach cancer in sixty-five Chinese counties. Cancer Epidemiology 1 113-118
117. Kokkola A, Valle J, Haapainen R, Sipponen P, Kivilaakso E and Puolakkainen P (1996) Helicobacter pylori infection in young patients with gastric carcinoma. Scandinavian Journal of Gastroenterology 31 643-647
118. Kosunen TU, Aromaa A, Knekt P et al (1997) Helicobacter antibodies in 1973 and 1994 in the adult population of Vammala Finland. Epidemiology and Infection 119 29-34
119. Kriebel D and Jowett D (1979) Stomach cancer mortality in the north central states: high risk is not limited to the foreign-born. Nutrition and Cancer 1 8-12
120. Kuipers EJ and Meuwissen SGM (1996) Helicobacter pylori and gastric carcinogenesis. Scandinavian Journal of Gastroenterology 31 (Supplement 218) 103-105
121. Kuipers EJ, Gracia-Casanova M, Pena AS et al (1993) Helicobacter pylori serology in patients with gastric carcinoma. Scandinavian Journal of Gastroenterology 28 433-437
122. Kuipers EJ, Perez-Perez GI, Meuwissen SGM and Blaser MJ (1995a) Helicobacter pylori and atrophic gastritis: importance of the cagA status. Journal of the National Cancer Institute 87 1777-1780
123. Kuipers EJ, Uyterlinde AM, Pena AS et al (1995b) Long-term sequelae of Helicobacter pylori gastritis. Lancet 345 1525-1528
124. Kurtenkov O, Klaamas K, Cavacci A and Wadstrom T (1997) IgG immune response to a recombinant fragment of cagA in patients with gastric cancer: relation to the ABO(h) blood group phenotype and the stage of cancer. Gut 41 (Supplement 1) A48
125. Leoncini L, Vindigni C, Megha T et al (1993) Epstein-Barr virus and gastric cancer: data and unanswered questions. International Journal of Cancer 53 898-901
126. Levine PH, Stemmermann G and Lennette ET (1995) Elevated antibody titres to Epstein-Barr virus prior to the diagnosis of Epstein-Barr virus associated gastric adenocarcinoma. International Journal of Cancer 60 642-644
127. Li D, Gao X and Guan H (1995) Relationship between Helicobacter pylori infection and diffuse and intestinal types stomach cancer. Chung Hua Liu 16 299-302
128. Lin JT, Wang JT, Wang TH, Wu MS, Lee TK and Chen CJ (1993a) Helicobacter pylori infection in a randomly selected population healthy volunteers and patients with gastric ulcer and gastric adenocarcinoma. Scandinavian Journal of Gastroenterology 28 1067-1072
129. Lin JT, Wang JT, Wu MS, Huang SC and Wang TH (1993b) Serum levels of pepsinogen I and gastrin in gastric carcinoma: the influence of Helicobacter pylori infection and tumor characteristics. Hepatogastroenterology 40 600-603
130. Lin JT, Wang LY, Wang JT, Wang TH and Chen CJ (1995a) Ecological study of association between Helicobacter pylori infection and gastric cancer in Taiwan. Digestive Diseases and Sciences 40 385-388
131. Lin JT, Wang LY, Wang JT, Wang TH, Yang CS and Chen CJ (1995b) A nested case-control study on the association between Helicobacter pylori infection and gastric cancer in a cohort of 9775 men in Taiwan. Anticancer Researh 15 603-606
132. Liston R, Pitt MA and Banerjee AK (1996) IgA ELISA antibodies and detection of Helicobacter pylori in elderly patients. Lancet 347 269
133. Loffeld RJFL, Willems I, Flendrig JA and Arends JW (1990) Helicobacter pylori and gastric carcinoma. Histopathology 17 537-541
134. Marshall BJ, Armstrong JA, McGechie DB and Glancy RJ (1985) Attempt to fulfil Koch's postulates for pyloric Campylobacter. Medical Journal of Australia 142 436-439
135. Matsumoto T, Iida M and Shimizu M (1997) Regression of mucosa-associated lymphoid-tissue lymphoma of rectum after eradication of Helicobacter pylori. Lancet 350 115-116
136. McCulloch P (1996) Gastric cancer. Postgraduate Medical Journal 72 450-457
137. McMichael AJ, McCall MG and Hartshorne JM (1980) Patterns of gastro-intestinal cancer in European migrants to Australia: the role of dietary change. International Journal of Cancer 25 431-437
138. Meining A, Bayerdorffer E, Miehlke S and Stolte M (1997) Is intestinal metaplasia a real risk factor for gastric carcinoma? Gut 41 (Supplement 1) A50
139. Menegatti M, Vaira D, Miglioli M et al (1995) Helicobacter pylori in patients with gastric and nongastric cancer. American Journal of Gastroenterology 90 1278-1281
140. Michetti P, Wadstrom T, Kraehenbuhl JP, Lee A, Kreiss C and Blum AL (1996) Frontiers in Helicobacter pylori research: pathogenesis host response vaccine development and new therapeutic approaches. European Journal of Gastroenterology and Hepatology 8 717-722
141. Miehlke S, Kim JG, Small SM and Graham DY (1995) Is the presence of the cagA gene in Helicobacter pylori associated with gastric adenocarcinoma? American Journal of Gastroenterology 90 1587
142. Miehlke S, Kibler K, Kim JG, Figura N, Small SM and Graham DY (1996) Allelic variation in the cagA gene of Helicobacter pylori obtained from Korea compared to the United States. American Journal of Gastroenterology 91 1322-1325
143. Miglio F, Miglioli M, Holton J et al (1992) Prevalence of Helicobacter pylori in patients with gastric carcinoma. Irish Journal of Medical Science 161 (Supplement 10) [Abstract GCE 37]
144. Miller AB (1982) Risk factors from geographic epidemiology for gastrointestinal cancer. Cancer 50 2533-2540
145. Min KW, Holmquist S, Peiper SC and O'Leary TJ (1991) Poorly differentiated adenocarcinoma with lymphoid stroma (lymphoepithelial-like carcinomas) of the stomach: report of three cases with Epstein-Barr-virus genome demonstrated by the polymerase chain reaction. American Journal of Clinical Pathology 96 219-227
146. Mitchell HM, Hazell SL, Li YY and Hu PJ (1996) Serological response to specific Helicobacter pylori antigens: antibody against CagA antigen is not predictive of gastric cancer in a developing country. American Journal of Gastroenterology 91 1785-1788
147. Montalban C, Manzanal A, Boixeda D, Redondo C and Bellas C (1995) Treatment of low-grade gastric MALT lymphoma with Helicobacter pylori eradication. Lancet 345 798-799
148. Montalban C, Manzanal A, Boixeda D, Calleja JL and Bellas C (1996) Helicobacter pylori eradication for the treatment of low grade gastric MALT lymphoma: follow up together with sequential molecular studies. Annals of Oncology 7 (Supplement 13) S65
149. Morgner A, Bayerdorffer E, Neubauer A et al (1997) Remission of primary gastric low-grade MALT lymphoma after cure of Helicobacter pylori infection - German MALT lymphoma trial. Gut 41 (Supplement 1) A46
150. Morris A and Nicholson G (1987) Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH. American Journal of Gastroenterology 82 192-199
151. Muñoz N (1994) Is Helicobacter pylori a cause of gastric cancer? An appraisal of the seroepide-miological evidence. Cancer Epidemiology Biomarkers and Prevention 3 445-451
152. Muñoz N (1996) Gastric cancer and Helicobacter pylori. European Journal of Cancer Prevention 5 405-408
153. Muñoz N Gastric cancer and Helicobacter pylori, In: Correa P and Palli B (eds) (in press)
154. Muñoz N and Pisani P (1994) Helicobacter pylori and gastric cancer. European Journal of Gastroenterology and Hepatology 6 1097-1103
155. Muñoz N, Vivas J, Buiatti E, Kato I and Oliver W (1996) Chemoprevention trial on precancerous lesions of the stomach in Venezuela: summary of study design and baseline data, In: Stewart BW, McGregor D and Kleihues P (eds). Principles of Chemoprevention (International Agency on Cancer Research Publication No 139) 125-133
156. Murray CJL and Lopez AD (1997a) Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 349 1269-1276
157. Murray CJL and Lopez AD (1997b) Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 349 1498-1504
158. Muszynski J, Dzierazanowska D, Sieminska J, Bogdanska M, Vogt E and Ehrmann A (1995) Is Helicobacter pylori infection a real risk factor for gastric carcinoma? Scandinavian Journal of Gastroenterology 30 647-651
159. Nagashima R, Takeda H, Maeda K, Ohno S and Takahashi T (1996) Regression of duodenal mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori. Gastroenterology 111 1674-1678
160. National Institutes of Health Consensus Development Panel (1994) Helicobacter pylori in peptic ulcer disease. Journal of the American Medical Association 272 65-69
161. Neugut AI, Hayek M and Howe G (1996) Epidemiology of gastric cancer. Seminars in Oncology 23 281-291
162. Ng TM, Fock KM, Khim MM et al (1997) Gastric cancer and H pylori infection in Singapore: lack of association with cagA status Gut 41 (Supplement 1) A47
163. Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez GI and Blaser MJ (1991) Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. New England Journal of Medicine 325 1132-1136
164. Palli D, Decarli A, Cipriani F et al (1993) Helicobacter pylori antibodies in areas of Italy at varying gastric cancer risk. Cancer Epidemiology Biomarkers and Prevention 2 37-40
165. Parsonnet J (1995) The incidence of Helicobacter pylori infection. Alimentary Pharmacology and Therapeutics 9 (Supplement 2) 45-51
166. Parsonnet J, Friedman GD, Vandersteen DP et al (1991a) Helicobacter pylori infection and the risk of gastric carcinoma. New England Journal of Medicine 325 1127-1131
167. Parsonnet J, Vandersteen D, Goates J, Sibley RK, Pritikin J and Chang Y (1991b) Helicobacter pylori infection in intestinal- and diffuse-type adenocarcinomas. Journal of the National Cancer Institute 83 640-643
168. Parsonnet J, Hansen S, Rodriguez L et al (1994) Helicobacter pylori infection and gastric carcinoma. New England Journal of Medicine 330 1267-1271
169. Parsonnet J, Harris RA, Hack HM and Owens DK (1996) Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials. Lancet 348 150-154
170. Parsonnet J, Friedman GD, Orentreich N and Vogelman H (1997) Risk factor for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 40 297-301
171. Pasztorova I, Chinyama C, Filipe MI, Smith P and Sanderson JD (1997) Regression of gastric intestinal metaplasia after eradication of Helicobacter pylori: a prospective study. Gut 41 (Supplement 1) A55
172. Peek RM, Moss SF, Tham KT et al (1997) Helicobacter pylori cagA+ strains and dissociation of gastric epithelial cell proliferation from apoptosis. Journal of the National Cancer Institute 89 863-868
173. + proportion of Helicobacter pylori infections. International Journal of Cancer 72 453-456
174. Perez-Perez GI, Groves F, Zhang L, You WC, Fraumeni JF and Blaser MJ (1997b) Relationship between CagA seroprevalence and gastric cancer rates in Chinese populations. Gut 41 (Supplement 1) A49
175. Peto R (1976) Two properties of multiple regression analysis and regression to the mean (and regression from the mean), In: Fletcher CM, Peto R, Tinker CM and Speizer FE (eds). The Natural History of Chronic Bronchitis and Emphysema: An Eight Year Study of Early Chronic Obstructive Lung Disease in Working Men in London, pp 218-223, Oxford University Press, Oxford, United Kingdom
176. Peto R (1990) General reflections on principles and purposes: indirect and direct purposes of the present monograph, In: Junshi C, Campbell TC, Junyao L and Peto R (eds). Diet Life-Style and Mortality in China: A Study of the Characteristics of 65 Chinese Counties, pp 72-78, Oxford University Press, Oxford, United Kingdom
177. Peto R, Lopez AD, Boreham J, Thun M and Heath C (1994) Mortality From Smoking in Developed Countries 1950-2000: Indirect Estimates from National Vital Statistics pp 524-535, Oxford University Press, Oxford, United Kingdom
178. Pounder RE and Ng D (1995) The prevalence of Helicobacter pylori infection in different countries. Alimentary Pharmacology and Therapeutics 9 (Supplement 2) 33-39
179. Rauws EAJ, Langenberg W, Houthoff HJ, Zanen HC and Tytgat GNJ (1988) Campylobacter pyloridis-associated chronic active antral gastritis A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology 94 33-40
180. Roggero E, Zucca E, Pinotti G et al (1995) Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue. Annals of Internal Medicine 122 767-769
181. Rosenstock SJ, Andersen LP, Bonnevie O and Jorgensen T (1996) Sero-conversion and sero-reversion in IgG antibodies to H pylori: an 11-year follow-up of 2523 randomly selected Danes. Gut 39 (Supplement 3) [abstract A3]
182. Rosenwaike I (1984) Cancer mortality among Puerto Rican-born residents in New York City. American Journal of Epidemiology 119 177-185
183. Rudi J, Muller M, von Herbay A et al (1995) Lack of association of Helicobacter pylori sero-prevalence and gastric cancer in a population with low gastric cancer incidence. Scandinavian Journal of Gastroenterology 30 958-963
184. Rudi J, Kolb C, Maiwald M et al (1997) Serum antibodies against Helicobacter pylori proteins VacA and CagA are associated with increased risk for gastric adenocarcinoma. Digestive Diseases and Sciences 42 1652-1659
185. Rugge M, Cassaro M, Leandro G et al (1996) Helicobacter pylori in promotion of gastric carcinogenesis. Digestive Diseases and Sciences 41 950-955
186. Sackmann M, Morgner A, Rudolph B et al and MALT Lymphoma Study Group (1998) Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. Gastroenterology 113 1087-1090
187. Sakaki N, Momma K, Egawa N, Yamada Y, Kan T and Ishiwata J (1995) The influence of Helicobacter pylori infection on the progression of gastric mucosal atrophy and occurrence of gastric cancer. European Journal of Gastroenterology
188. Savio A, Franzin G, Wotherspoon AC et al (1995) Long-term effect of anti-Helicobacter pylori therapy on gastric MALT lymphoma: histological and molecular evaluation of 15 cases. Gut 37 A23
189. Savio A, Franzin G, Wotherspoon AC et al (1996) Diagnosis and posttreatment follow-up of Helicobacter pylori-positive gastric lymphoma of mucosa-associated lymphoid tissue: histology polymerase chain reaction or both? Blood 87 1255-1260
190. Schlemper RJ, van der Werf SDJ, Vandenbroucke JP, Biemond I and Lamers CBHW (1995) Seroepidemiology of gastritis in Japanese and Dutch working populations: evidence for the development of atrophic gastritis that is not related to Helicobacter pylori. Gut 37 199-204
191. Shibata D and Weiss LM (1992) Epstein-Barr-virus-associated gastric adenocarcinoma. American Journal of Pathology 140 769-774
192. Shibata D, Tokunaga M, Uemura Y et al (1991) Epstein-Barr viral sequences are commonly present in the carcinoma cells of gastric lympho-epithelioma-like carcinoma. American Journal of Pathology 139 469-474
193. Shibata D, Hawes D, Stemmermann GN and Weiss LM (1993) Epstein-Barr-virus-associated gastric adenocarcinoma among Japanese Americans in Hawaii. Cancer Epidemiology Biomarkers and Prevention 2 213-217
194. Shimoyama T, Fukuda S, Tanaka M et al (1997) High prevalence of the CagA-positive Helicobacter pylori strains in Japanese asymptomatic patients and gastric cancer patients. Scandinavian Journal of Gastroenterology 32 465-468
195. Shousha S and Luqmani YA (1997) Epstein-Barr virus in gastric carcinoma and adjacent normal gastric and duodenal mucosa. Journal of Clinical Pathology 47 695-698
196. Sierra R, Muñoz N, Pena AS et al (1992) Antibodies to Helicobacter pylori and pepsinogen levels in children from Costa Rica: comparison of two areas with different risks for stomach cancer. Cancer Epidemiology Biomarkers and Prevention 1 449-454
197. Siman JH, Forsgren A and Floren CH (1997) Association between Helicobacter pylori and gastric carcinoma in the city of Malmo Sweden - a prospective study. Gut 41 (Supplement 1) A45
198. Sipponen P, Seppala K, Varis K et al (1980) Intestinal metaplasia with colonie-type sulphomucins in the gastric mucosa: its association with gastric carcinoma. Acta Pathologica Microbiologica Scandinavia Section A 88 217-224
199. Sipponen P, Kekki M, Haapakoski J, Ihamaki T and Siurala M (1985) Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. International Journal of Cancer 35 173-177
200. Sipponen P, Kosunen TU, Valle J, Rihela M and Seppala K (1992) Helicobacter pylori infection and chronic gastritis in gastric cancer. Journal of Clinical Pathology 45 319-323
201. Sipponen P, Hyvarinen H, Seppala K and Blaser MJ (1998) Review article: pathogenesis of the transformation from gastritis to malignancy. Alimentary Pharmacology and Therapeutics 12 (Supplement 1) 61-71
202. Sonnenberg A and Inadomi JM (1998) Review article: medical decision models of Helicobacter pylori therapy to prevent gastric cancer. Alimentary Pharmacology and Therapeutics 12 (Supplement 1) 111-121
203. Stolte M and Eidt S (1989) Lymphoid follicles in antral mucosa: immune response to Campylobacter pylori? Journal of Clinical Pathology 42 1269-1271
204. Stolte M and Eidt S (1993) Healing gastric MALT lymphomas by eradicating H pylori? Lancet 342 568-569
205. Swerdlow AJ, dos Santos Silva I, Reid A, Qiao Z, Brewster DH and Arrundale J (1998) Trends in cancer incidence and mortality in Scotland: description and possible explanations. British Journal of Cancer 17 (Supplement 13) 1-54
206. Talley NJ and Xia HH (1996) Ethnicity as a risk factor for Helicobacter pylori infection and gastric cancer: environment genetics or both? Australia and New Zealand Journal of Medicine 26 628-631
207. Talley NJ, Zinsmeister AR, Weaver A et al (1991) Gastric adenocarcinoma and Helicobacter pylori infection. Journal of the National Cancer Institute 83 1734-1739
208. Testoni PA, Colombo E, Cottani L et al (1996) Helicobacter pylori serology in chronic gastritis with antral atrophy and negative histology for Helicobacter-like organisms Journal of Clinical Gastroenterology 22 182-185
209. Tokumaru K, Kojima T, Satoh K et al (1997) CagA gene of Helicobacter pylori is a not a carcinogenic marker in Japanese patients. Gut 41 (Supplement 1) A47
210. Tredaniel J, Boffetta P, Buiatta E, Saracci R and Hirsch A (1997) Tobacco smoking and gastric cancer: review and meta-analysis. International Journal of Cancer 72 565-573
211. Tsugane S, Kabuto M, Imai H et al (1993) Helicobacter pylori dietary factors and atrophic gastritis in five Japanese populations with different gastric cancer mortality. Cancer Causes and Control 4 297-305
212. Tucci A, Biasco G and Paparo GF (1997) Effect of eradication of Helicobacter pylori in patients with fundic atrophic gastritis. New England Journal of Medicine 336 957-958
213. Tulinius H, Ogmundsdottir H, Kristinsson KG, Tryggvadottir L, Jonasson I and Sigfusson N (1997) A retrospective case-control study of H pylori infection and subsequent gastric cancer in Iceland. IARC Annual Meeting November, 1997 [Abstract]
214. Uemura N, Mukai T, Okamoto S et al (1997) Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiology Biomarkers and Prevention 6 639-642
215. Uemura Y, Tokunaga M and Arikawa J (1994) A unique morphology of Epstein-Barr virus related to early gastric cancer. Cancer Epidemiology Biomarkers and Prevention 3 607-611
216. Valle J, Seppala K, Sipponen P and Kosunen T (1991) Disappearance of gastritis after eradication of Helicobacter pylori: a morphometric study. Scandinavian Journal of Gastroenterology 26 1057-1065
217. Valle J, Kekki M, Sipponen P, Ihamaki T and Siurala M (1996) Long-term course and consequences of Helicobacter pylori gastritis. Scandinavian Journal of Gastroenterology 31 546-550
218. van der Hulst RWM, Rauws EAJ, Koycu B et al (1997) The influence of cure of H pylori infection on the long term sequelae of gastritis: a prospective follow-up study. Gut 41 (Supplement 1) A54
219. Varis K (1983) Surveillance of pernicious anemia, In: Sherlock P, Morson BC, Barbara L and Veronesi U. Precancerous Lesions of the Gastrointestinal Tract, pp 189-194, Raven Press, New York
220. Veldhuyzen van Zanten SJO (1995) Do socio-economic status marital status and occupation influence the prevalence of Helicobacter pylori infection? Alimentary Pharmacology and Therapeutics 9 (Supplement 2) 41-44
221. Wald NJ, Law MR, Morris JK and Bagnall AM (1997) Helicobacter pylori and mortality from ischaemic heart disease: a negative result from a large prospective study. British Medical Journal 315 1199-1201
222. Warren JR and Marshall BJ (1983) Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet i 1273
223. Watanabe Y, Kurata JH, Mizuno S et al (1998) Helicobacter pylori infection and gastric cancer: a nested case-control study in a rural area of Japan. Digestive Diseases and Sciences 42 1383-1387
224. Webb PM and Forman D (1995) Helicobacter pylori as a risk factor for cancer. Bailliere's Clinical Gastroenterology 9 563-582
225. Webb PM, Yu MC, Forman D et al (1996) An apparent lack of association between Helicobacter pylori infection and risk of gastric cancer in China. International Journal of Cancer 67 603-607
226. Weber DM, Dimopoulos MA, Anandu DP, Pugh WC and Steinbach G (1994) Regression of gastric lymphoma of mucosa-associated lymphoid tissue with antibiotic therapy for Helicobacter pylori. Gastroenterology 107 1835-1838
227. Wee A, Kang JY and Teh M (1992) Helicobacter pylori and gastric cancer: correlation with gastritis intestinal metaplasia and tumour histology. Gut 33 1029-1032
228. Weel JFL, van der Hulst RWM, Gerrits Y et al (1996) The interrelationship between cytotoxin-associated gene-A, vacuolating cytotoxin, and Helicobacter pylori-related diseases. Journal of Infectious Diseases 173 1171-1175
229. - Helicobacter pylori infection. Journal of Infectious Diseases 176 1641-1644
230. Wotherspoon AC (1998) Helicobacter pylori infection and gastric lymphoma. British Medical Bulletin 54 79-85
231. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR and Isaacson PG (1991) Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 338 1175-1176
232. Wotherspoon AC, Doglioni C and Diss TC (1993) Regression of pimary low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342 575-577
233. Wotherspoon AC, Doglioni C, de Boni M, Spencer J and Isaacson PG (1994) Antibiotic treatment for low-grade gastric MALT lymphoma. Lancet 343 1503
234. Wyatt JI and Rathbone BJ (1988) Immune response of the gastric mucosa to Campylobacter pylori. Scandinavian Journal of Gastroenterology 23 (Supplement 142) 44-49
235. Zucca E and Roggero E (1996) Biology and treatment of MALT lymphoma: the state-of-the-art in 1996. Annals of Oncology 7 787-792